FDA Drug Application (076198) for BALZIVA-21 by BARR

Back to FDA Applications sponsored by BARR

Application Number076198
Product Number001
FormTABLET;ORAL-21
Dosage0.035MG;0.4MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBALZIVA-21
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE82


Back to FDA Applications sponsored by BARR